Novel KIT mutation presenting as marked lentiginosis

Tran, Alain Khoi; Pearce, Annette; López-Sánchez, Marcos; Pérez-Jurado, Luís A.; Barnett, Christopher

doi:10.1111/pde.13952

Cited by 2 publications

(5 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…T. Takeichi et al reported the c. 2485G > C mutation in exon 17 of KIT in a Japanese pedigree that manifested as progressive hyperpigmentation and lentigines unassociated with any other familiar systemic disease ( 5 ). Almost at the same time, Alain K. et al revealed the same mutation in a 6-year-old girl who presented with atypical lentiginosis and hyperpigmentation without systemic disorders ( 1 ).…”

Section: Discussionmentioning

confidence: 88%

“…Apart from somatic mutations of KIT in melanomas, germline KIT mutations are reported to be associated with other pigmented disorders, often accompanied by GIST or mastocytosis ( 1 , 2 , 4 – 7 ). However, two independent groups have recently revealed a new missense mutation of KIT in patients with hyperpigmentation and lentigines without systemic disorders.…”

Section: Discussionmentioning

confidence: 99%

“…Lentigines are usually a benign proliferation of epidermal melanocytes, which are commonly seen in sun-exposed areas. However, numerous or generalized lentigines might be an indicator of systemic disorders, including Peutz-Jeghers syndrome, Carney complex, LEOPARD syndrome, Dowling-Degos disease, PTEN hamartoma tumor syndrome, and familial progressive hyperpigmentation with or without hypopigmentation ( 1 ).…”

Section: Introductionmentioning

confidence: 99%

“…There are two reports of a missense mutation at the kinase activation loop of KIT (c. 2485G > C) that is associated with hyperpigmentation and lentigines without GIST or mastocytosis ( 1 , 5 ). In this study, we reported a Chinese pedigree with progressive hyperpigmentation and generalized lentigines in which the same missense mutation of KIT was confirmed.…”

Section: Introductionmentioning

confidence: 99%

“…It plays an important role in the development and regulation of melanocytes, mast cells, germ cells, the interstitial cells of Cajal, and hematopoietic progenitor cells ( 2 , 3 ). KIT mutations are reported to be associated with a variety of cutaneous disorders, including piebaldism, mastocytosis, hyperpigmentation, and lentigines ( 1 , 4 – 8 ). They are also involved in malignancies including testicular germ cell tumor, acute myelogenous leukemia, gastrointestinal stromal tumor (GIST), and melanomas ( 2 , 6 , 9 ).…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Case Report: A Missense Mutation of KIT in Hyperpigmentation and Lentigines Unassociated With Systemic Disorders: Report of a Chinese Pedigree and a Literature Review

2022

View full text Add to dashboard Cite

BackgroundKIT is a proto-oncogene that is involved in the proliferation, survival, and regulation of melanocytes, mast cells, and the interstitial cells of Cajal. Mutations of KIT have been reported to be associated with hyperpigmentation and lentigines, mastocytosis, and gastrointestinal stromal tumors (GISTs). Some hotspot mutations of KIT have been reported to be associated with mastocytosis and GISTs, while the relationship between KIT mutations and hyperpigmentation and lentigines has not been fully elucidated.MethodsIn this study, we presented a three-generation Chinese pedigree with progressive hyperpigmentation and generalized lentigines inherited in an autosomal dominant pattern. High-throughput sequencing was performed to capture genetic variations in peripheral blood samples of the proband. Also, Sanger sequencing was performed to further verify the result. We also reviewed previous literature on KIT mutations with hyperpigmentation and lentigines.ResultsA missense mutation of the KIT gene was identified: c. 2485G > C, which was co-segregated in the proband and his insulted father. Germline KIT mutations presenting as generalized hyperpigmentation and lentigines without systemic disorders are rare, with only two reports of c. 2485G > C mutation associated with this phenotype in previous literature.ConclusionOur pedigree, together with those two reports, indicates a possible phenotype-genotype correlation of this germline KIT mutation, which might be helpful for genetic counseling, further functional segregation of KIT, and design of targeted therapy in the future.

show abstract

Section: Discussionmentioning

confidence: 88%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Case Report: A Missense Mutation of KIT in Hyperpigmentation and Lentigines Unassociated With Systemic Disorders: Report of a Chinese Pedigree and a Literature Review

2022

View full text Add to dashboard Cite

show abstract

Chinese Pedigree with Hereditary Gastrointestinal Stromal Tumors: A Case Report and Literature Review

Liu

Yang

et al. 2023

IJMS

View full text Add to dashboard Cite

Familial gastrointestinal stromal tumor (GIST) is a rare autosomal dominant genetic disorder with only a few affected families reported to date. Here, we report a case of familial GISTs harboring a novel germline mutation within exon 18 of KIT. A 58-year-old male patient presented with gastric subepithelial lesions accompanied by cutaneous hyperpigmentation, which were subsequently diagnosed as multinodular GISTs. Endoscopic surgery was initially conducted to remove the larger lesions, and pathological examinations were then conducted for the diagnosis of GISTs. Family history revealed that some other family members had similar cutaneous pigmentations. Whole-exome sequencing was used to search for potential driver mutations, and Sanger sequencing was used for mutation validation. A novel primary driver mutation of KIT (c.G2485C, p.A829P) was detected in these hereditary GISTs, which has been reported in some targeted chemotherapy-resistant GISTs. Cell models were subsequently established for the rapid screening of candidate drugs and exploring potential mechanisms. This mutation could lead to cell proliferation and imatinib resistance by ligand-independent activation of KIT; however, ripretinib administration was identified as an applicable targeted therapy for this mutation. The mutation activated the JAK/STAT3 and MAPK/ERK pathways, which could be inhibited by ripretinib administration. To the best of our knowledge, this is the first report of the KIT-A829P mutation in familial GISTs, complementing the pathogenesis of familial GISTs and providing valuable information for the precision treatment of this disease.

show abstract

Novel KIT mutation presenting as marked lentiginosis

Cited by 2 publications

References 12 publications

Case Report: A Missense Mutation of KIT in Hyperpigmentation and Lentigines Unassociated With Systemic Disorders: Report of a Chinese Pedigree and a Literature Review

Case Report: A Missense Mutation of KIT in Hyperpigmentation and Lentigines Unassociated With Systemic Disorders: Report of a Chinese Pedigree and a Literature Review

Chinese Pedigree with Hereditary Gastrointestinal Stromal Tumors: A Case Report and Literature Review

Contact Info

Product

Resources

About